Menu
We are focused on developing, co-developing, in-licensing, manufacturing, marketing, distribution and selling of innovative pharmaceutical products Viz bioequivalent generics, Value added generics (VAG’s), 505(b)(2), Para IV patent challenges, Niche therapeutics and NDDS dosage forms. The company operates through its own development and manufacturing hub in India and Co-development/in-licensing partnerships across the globe.
“To care for the well-being and happiness of the people.”
Creekwood Pharmaceuticals, LLC is engaged in development, co- development, in licensing, manufacturing, distribution,sales and marketing of innovative pharmaceutical products, designed to help patients with serious, acute or chronic conditions to better manage their disease resulting in overall well-being and happiness.
The five core values which guide our organization.
We work with uncompromising honesty and integrity in what we do and how we do.
We value people and the environment around us. We treat people with dignity and respect. We are compassionate towards people & the environment..
Competitive advantage through innovation.
Relentless focus on customers by servicing customer needs and ensuring we are responsive to customer demands, thereby creating a dedicated customer base.
We work with collaborative teamwork and encourage each other to achieve challenging goals.
| Strength | 120 mg |
| NDC | 82619-102-01 |
| GTN | 382619102017 |
| OTC/Rx | RX |
| TE Code | BX |
| Ref Brand | FENOGLIDE |
| Therapeutic Class | Primary Hypercholesterolemia, Hypertriglyceridemia |
| Strength | 40 mg |
| NDC | 82619-101-01 |
| GTN | 382619101010 |
| OTC/Rx | RX |
| TE Code | BX |
| Ref Brand | FENOGLIDE |
| Therapeutic Class | Primary Hypercholesterolemia, Hypertriglyceridemia |
| Product Details | 12's Pack | 18's Pack |
|---|---|---|
| Strength | 10 mg | 10 mg |
| NDC | 82619-112-04 | 82619-112-05 |
| GTN | 382619112047 | 382619112054 |
| OTC/Rx | RX | RX |
| TE Code | AB | AB |
| Ref Brand | MAXALT | MAXALT |
| Therapeutic Class | Antimigraine | Antimigraine |
| Product Details | 12's Pack | 18's Pack |
|---|---|---|
| Strength | 5 mg | 5 mg |
| NDC | 82619-111-04 | 82619-111-05 |
| GTN | 382619111040 | 382619111057 |
| OTC/Rx | RX | RX |
| TE Code | AB | AB |
| Ref Brand | MAXALT | MAXALT |
| Therapeutic Class | Antimigraine | Antimigraine |
| Strength | 8 mg |
| NDC | 82619-114-02 |
| GTN | 382619114027 |
| OTC/Rx | RX |
| TE Code | AB |
| Ref Brand | RAPAFLO |
| Therapeutic Class | Alpha‑1 adrenergic receptor antagonist |
| Strength | 8 mg |
| NDC | 82619-114-01 |
| GTN | 382619114010 |
| OTC/Rx | RX |
| TE Code | AB |
| Ref Brand | RAPAFLO |
| Therapeutic Class | Alpha‑1 adrenergic receptor antagonist |
| Strength | 4 mg |
| NDC | 82619-113-01 |
| GTN | 382619113013 |
| OTC/Rx | RX |
| TE Code | AB |
| Ref Brand | RAPAFLO |
| Therapeutic Class | Alpha‑1 adrenergic receptor antagonist |
| Strength | 1.25 mg+ 2.5 mg |
| NDC | 82619-104-01 |
| GTN | 382629104011 |
| OTC/Rx | RX |
| TE Code | AB |
| Ref Brand | Covaryx |
| Therapeutic Class | Hormone |
| Strength | 0.625 mg + 1.25 mg |
| NDC | 82619-103-01 |
| GTN | 382619103014 |
| OTC/Rx | RX |
| TE Code | AB |
| Ref Brand | Covaryx |
| Case Qty | 12 |
| Therapeutic Class | Hormone |